Viral Hepatitis For Nurses

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 44

ACUTE VIRAL

HEPATITIS

CLINICAL PRESENTATION.
DIGNOSIS.
EPEDEMOLOGY OF VIRAL
HEPATITIS INFECTION A,B,C
MANAGEMENT.
Viral Hepatitis - Overview
Type of Hepatitis
A B C D E
Source of feces blood/ blood/ blood/ feces
virus blood-derived blood-derived blood-derived
body fluids body fluids body fluids
Route of fecal-oral percutaneous percutaneous percutaneous fecal-oral
transmission permucosal permucosal permucosal

Chronic no yes yes yes no


infection

Prevention pre/post- pre/post- blood donor pre/post- ensure safe


exposure exposure screening; exposure drinking
immunization immunization risk behavior immunization; water
modification risk behavior
modification
DIAGNOSIS OF HEPATITIS

• Patient history
• Physical examination
• Liver function tests
• Serologic tests
SYMPTOMS AND SIGNS

Pre-icteric phase
1.Anorexia
2.Fatigue
3.Nausea
4.Vomiting
5.Arthralgia
6.Myalgia
7.Headache
8.Photophobia
9.Pharyngitis
CONT.

• Icteric phase::
1. Enlarged liver
2. Tender upper quadrant
3. Discomfort
4. Splenomegaly (10-20%)
5. General adenopathy

• Post-icteric phase
• 1. cessation of the above symptoms
• Complications: liver cirrhosis, hepatitis
coma and death.
LAB FINDINGS

1. L FT increase >5-10 times of


normal
2. Markers of hepatitis B or C or A
might be positive
3. RFTs
PATHOLOGICAL FINDINGS

1. Pan lobular infiltration with mononuclear


cells
2. Hepatic cell necrosis
3. Reticulum framework are intact
DD:

1. Infectious Mononucleosis
2. Drug Induced Hepatitis
3. Chronic Hepatitis.
4. Alcohol Hepatitis
5. Cholecystitis, Cholelithiasis
6. Bacterial hepatitis etc
COMPLICATIONS

1.Chronic hepatitis  cirrhosis- HCC

2.Fulmnant hepatitis
FULMINANT HEPATITIS

• Definition: Hepatic Failure Within 8 Weeks


Of Onset Of Illness.
• Manifestation: Encephalopathy and
Prolonged PT
• Histopathology: Massive Hepatic Necrosis.
Hepatitis B - Clinical Features
• Incubation period: Average 60-90 days
Range 45-180 days
• Clinical illness (jaundice): <5 yrs, <10%
5 yrs, 30%-50%
• Acute case-fatality rate: 0.5%-1%
• Chronic infection: <5 yrs, 30%-90%
5 yrs, 2%-10%
• Premature mortality from
chronic liver disease: 15%-25%
HBV INFECTION

Factors affecting transmission ability

1.Replicative status
- HBeAg
- high HBVDNA

2.Route of infection
- percutaneous
- Transmucosal

3. Exposure frequency : Single vs. Multiple

4. Inoculums size : transfusion vs. needle stick


HEPATITIS B SEROLOGY

• anti-HBc exposure (IgM = acute)


• HBsAg  infection (carrier)
• anti-HBs  immunity
• HBeAg  viral replication
• anti-HBe  seroconversion
• HBV-DNA  viral replication
NATURAL HISTORY

Gow, BMJ 2001


Hepatitis B Virus
Modes of Transmission

• Sexual
• Parenteral
• Perinatal
Concentration of Hepatitis B Virus
in Various Body Fluids

Low/Not
High Moderate Detectable

blood semen urine


serum vaginal fluid feces
wound exudates saliva sweat
tears
breastmilk
POSSIBLE TRANSMISSION
ROUTE OF HBV IN SL

 1-Horisontal transmission (person to person) is the


main transmission route
 2-Perintal transmission (positive HBSAG mothers)
especially if they are HBEAG positive
 3- Heterosexual transmission
 4-Illegal injection drug use
 5- Contaminated equipment used for therapeutic
injections and other health care related procedures
 6- Folk medicine practice
 7-Blood and blood products transfusion without prior
screening
PREVENTION STRATEGIES OF
MINISTRY OF HEALTH IN SL
Introducing HBV vaccine in EPI
program; and
• Mandatory screening of blood donors and
expatriates.

• Vaccination of risk groups.

• Health education especially among medical

personnel .
THE CURRENT EPI IN THE SL

1. At birth BCG + HB1


2. At 6 weeks DPT1 + OPV1 Hb2
3. At 3 months DPT2 + OPV2
4. At 5 months DPT3 + OPV3
6. At 5months Measles HB3
7. At 12 months MMR
8. At 18 months (DPT + OPV) Booster 1
9. At 4-6 years (DPT + OPV) Booster 2
HCV INFECTION
Transmission of HCV
 Percutaneous
– Injecting drug use
– Clotting factors before viral inactivation
– Transfusion, transplant from infected donor
– Therapeutic (contaminated equipment, unsafe
injection practices)
– Occupational (needlestick)
 Permucosal
– Perinatal
– Sexual
Features of Hepatitis C Virus Infection
Incubation period Average 6-7 weeks
Range 2-26 weeks
Acute illness (jaundice) Mild (<20%)
Case fatality rate Low
Chronic infection 75%-85%
Chronic hepatitis 70% (most asx)
Cirrhosis 10%-20%
Mortality from CLD 1%-5%
Household Transmission of HCV
 Rare but not absent
 Could occur through percutaneous/mucosal
exposures to blood
– Theoretically through sharing of contaminated
personal articles (razors, toothbrushes)
– Contaminated equipment used for home therapies
• Injections*
• Folk remedies

*Reported in U.S.
Sexual Transmission of HCV
 Occurs, but efficiency is low
– Rare between long-term steady partners
– Factors that facilitate transmission between
partners unknown (e.g., viral titer)
 Accounts for 15-20% of acute and chronic
infections in the United States
– Sex is a common behavior
– Large chronic reservoir provides multiple
opportunities for exposure to potentially infectious
partners
Nosocomial Transmission of HCV

 Recognized primarily in context of outbreaks


 Contaminated equipment
– hemodialysis*
– endoscopy
 Unsafe injection practices
– plasmapheresis,* phlebotomy
– multiple dose medication vials
– therapeutic injections
* Reported in U.S.
NATURAL HISTORY

Marcellin, J Hepat 1999


PREVENTION OF HCV
TRANSMISSION
 Avoiding shared use of Razors or brushes
and any item that pierces the skin.
 Strict adherence of the universal
precautions in health facilities.
 Educating and training of HCW’s to the
proper use of standard precautions
 Folk medicine/ herbal ?!
HAV INFECTION
Perinatal Transmission of HCV
 Transmission only from women HCV-RNA
positive at delivery
– Average rate of infection 6%
– Higher (17%) if woman co-infected with HIV
– Role of viral titer unclear
 No association with
– Delivery method
– Breastfeeding
 Infected infants do well
– Severe hepatitis is rare
Occupational Transmission of HCV
 Inefficiently transmitted by occupational exposures
 Average incidence 1.8% following needle stick from
HCV-positive source
– Associated with hollow-bore needles
 Case reports of transmission from blood splash to eye
– No reports of transmission from skin exposures to blood
 Prevalence 1-2% among health care workers
– Lower than adults in the general population
– 10 times lower than for HBV infection
 Presence of recognized risk factor does not
necessarily equate with “increased risk”
Occupational Transmission of HCV
 Inefficiently transmitted by occupational exposures
 Average incidence 1.8% following needle stick from
HCV-positive source
– Associated with hollow-bore needles
 Case reports of transmission from blood splash to eye
– No reports of transmission from skin exposures to blood
 Prevalence 1-2% among health care workers
– Lower than adults in the general population
– 10 times lower than for HBV infection
 Presence of recognized risk factor does not
necessarily equate with “increased risk”
Perinatal Transmission of HCV
 Transmission only from women HCV-RNA
positive at delivery
– Average rate of infection 6%
– Higher (17%) if woman co-infected with HIV
– Role of viral titer unclear
 No association with
– Delivery method
– Breastfeeding
 Infected infants do well
– Severe hepatitis is rare
THANK YOU

You might also like